Efficacy and Safety of Adalimumab in Moderately to Severely Active Cases of Ulcerative Colitis: A Meta-Analysis of Published Placebo-Controlled Trials
Author:
Affiliation:
1. Department of Gastroenterology, Chinese PLA General Hospital of Jinan Military Command, Jinan, China
Publisher
The Editorial Office of Gut and Liver
Subject
Gastroenterology,Hepatology
Link
http://pdf.medrang.co.kr/ekjg/ekjg010-02-15.pdf
Reference31 articles.
1. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study);Solberg, IC;Scand J Gastroenterol,2009
2. Ulcerative colitis: epidemiology, diagnosis, and management;Feuerstein, JD;Mayo Clin Proc,2014
3. The impact of ulcerative colitis on patients’ lives compared to other chronic diseases: a patient survey;Rubin, DT;Dig Dis Sci,2010
4. Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab;Afif, W;Inflamm Bowel Dis,2009
5. Adalimumab in ulcerative colitis: two cases of mucosal healing and clinical response at two years;Barreiro-de Acosta, M;World J Gastroenterol,2009
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparing the Efficacy and Safety of Adalimumab and Vedolizumab in Treating Moderate to Severe Crohn’s Disease and Ulcerative Colitis;Gastroenterology Research;2023-12
2. Efficacy of Switching to Adalimumab for Maintenance of Remission Following Induction Therapy with Tacrolimus in Patients with Ulcerative Colitis;Journal of Clinical Medicine;2023-10-23
3. The Efficacy of Currently Licensed Biologics for Treatment of Ulcerative Colitis: A Literature Review;Cureus;2023-04-15
4. Guía GADECCU 2022 para el tratamiento de la colitis ulcerosa. Adaptación y actualización de la Guía GETECCU 2020;Gastroenterología y Hepatología;2023-03
5. Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study;Pharmaceutics;2022-11-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3